Intercept Blood SystemGirgin Ltd
The INTERCEPT Blood System for platelets and plasma is CE marked in accordance with requirements of the EU Medical Device Directive.
Some countries require additional local approvals of treated platelets and plasma, similar to standards for biologic
products (see list on previous page for these additional INTERCEPT approvals).
Multiple phase III/IV randomized controlled clinical trials have demonstrated its and. An extensive and unique hemovigilance database with over 60,000 transfusions has demonstrated safety and reliability in routine use.
Intercept Tanıtım Broşürleri